Wholesale QSC Tirzepatide 5mg/Vial - Pharmaceutical Grade Diabetes Research Material

QSC tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates significantly enhanced efficacy in both glucose regulation and weight management compared to single-receptor agonists like dulaglutide.

The molecular structure of QSC tirzepatide enables superior binding affinity, particularly to GIP receptors, while maintaining effective GLP-1 receptor activation. This dual mechanism produces more pronounced reductions in hyperglycemia than selective GLP-1 receptor agonists alone. Research indicates that QSC tirzepatide effectively mimics natural GIP activity at the GIP receptor.

Our QSC tirzepatide is supplied as a high-purity white powder with pharmaceutical-grade quality assurance. The compound has shown promising results in clinical research for improving glycemic control in type 2 diabetes models when combined with diet and exercise interventions.

For research use only. Not for human consumption.